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ABSTRACT: This study reports on a hand-held volatilome
analyzer for selective determination of clinically relevant bio-
markers in exhaled breath. The sensing platform is based on
electrospun polymer nanofiber-multiwalled carbon nanotube
(MWCNT) sensing microchannels. Polymer nanofibers of poly-
(vinylidene fluoride) (PVDF), polystyrene (PS), and poly(methyl
methacrylate) (PMMA) incorporated with MWCNT exhibits a
stable response to interferences of humidity and CO2 and provides
selective deformations upon exposure of exhaled breath target
volatilomes acetone and toluene, exhibiting correlation to diabetes
and lung cancer, respectively. The sensing microchannels “P1”
(PVDF-MWCNT), “P2” (PS-MWCNT), and “P3” (PMMA-
MWCNT) are integrated with a microfluidic cartridge (μ-card)
that facilitates collection and concentration of exhaled breath. The
volatilome analyzer consists of a conductivity monitoring unit,
signal conditioning circuitries and a low energy display module. A
combinatorial operation algorithm was developed for analyzing
normalized resistivity changes of the sensing microchannels upon exposure to breath in the concentration ranges between 35 ppb
and 3.0 ppm for acetone and 1 ppb and 10 ppm for toluene. Subsequently, responses of volatilomes from individuals in the
different risk groups of diabetes were evaluated for validation of the proposed methodology. We foresee that proposed
methodology provides an avenue for rapid detection of volatilomes thereby enabling point of care diagnosis in high-risk group
individuals.
The need for low-cost, lightweight, and high performancesensing devices is continuously increasing because of the
growing demand for miniaturized and portable instrumenta-
tion. Integrated biochips, microfluidic and sample enrichment
devices have attracted significant interest for portable
diagnostics. Noninvasive devices such as volatilome analyzers
are becoming common practice for early biomarker detection
and for continuous monitoring of disease development and
treatment. Breath analysis for diagnosis offers numerous
advantages, including rapid response time, simple sample
collection, and pretreatment, as compared to other matrices
such as saliva, feces, urine, blood, and sweat analyses.1−8
Moreover, recent efforts on identification metabolomics and
separation of 874 volatile organic compounds (VOCs) in
exhaled breath expedites utilization of VOCs as potential
biomarkers that correlate to various diseases.9−11 The impact of
research in metabolomics speeds up collective advancements in
preventive healthcare, drug toxicity studies, and disease
modeling biomarkers discovery, thereby gaining importance
in genomics and proteomics. Moreover, research on the
metabolomic fingerprinting provides rapid screening of
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physiological conditions, enabling development of novel
diagnostic approaches.12,13 Ongoing studies on diabetes,10,14−16
asthma,17 lung cancer,18−21 chronic obstructive pulmonary
disease (COPD),22 and breast cancer are being diagnosed by
screening of acetone,23,24 NO,25,26 toluene,27−29 and CO in
exhaled breath, respectively.30−34 Although VOCs are exhaled
due to high volatility,35 their concentrations in breath are still
very low (trace amount). Therefore, their detection often
requires sophisticated instruments such as gas chromatography
(GC), selected ion flow tube mass spectrometry (SIFT-MS),
and proton transfer reaction mass spectrometry (PTR-MS).36
However, recent advances in microfabrication and nano-
technology have enabled fabrication of point of care biosensors
that does not require bulky and sophisticated instrumenta-
tion.28,37,38
During the past decade, numerous nanomaterials have been
investigated in detail for VOC detection. Materials with
nanoscale dimensions, for example, nanoparticles of various
composition and size and carbon nanotubes (CNTs) offer
significant advantages such as large surface-to-volume ratio and
unique chemical, physical, and electrical properties.39 The large
active surface area of these materials makes them extremely
sensitive, as well as highly responsive.10 For instance, Chen et
al. proposed a microfabricated breath sensor consisting of a pair
of metal electrodes coated with a MWCNT layer with high
detection sensitivity.40 Qi et al. prepared cellulose-CNT
composite aerogel and recorded the resistivity changes in
response to organic vapors with a simple, sensitive and stable
methodology.41 Wang fabricated a hybrid structure of vertically
aligned CNT-PEDOT-PS in which PEDOT enabled detection
of analyte gases at low concentration and PS improved the
selectivity.42 Multiwall carbon nanotube/polyimide
(MWCNT/PI) composite film has been utilized for humidity
sensing, where MWCNT was used to improve the sensitivity
and linearity of the pristine PI sensor.43 Kybert et al. employed
a DNA-CNT sensor to differentiate volatile organic com-
pounds.44 These examples emphasize the potential of CNT-
based VOC sensors in exhaled breath diagnostics. Moon et al.
fabricated a volatilome analyzer based on Villi-like WO3
nanostructure to detect NO from exhaled breath. Inspired by
intestinal Villi they deposited WO3 at glancing angles to
increase the surface area of chemiresistor. The sensor could
selectively detect NO with a limit of detection of ∼88 ppt in a
mixture of ethanol, acetone, NH3, and CO, making it a
potential platform for asthma diagnostics.45 In a follow-up
study, a highly sensitive metal nanoparticle-based chemiresistive
electronic nose was reported with enhanced sensitivities of 534
ppt from 2.87 ppb for H2S, 4.45 ppb from 42.29 ppb for NH3,
and 206 ppt from 2.06 ppb for NO.28 Jung et al. developed a
carbon-based volatilome analyzer for NH3 and H2S sensor
consisting of a single-stranded DNA (ssDNA)-functionalized
graphene layer on a silicon substrate. They demonstrated
sensitive detection of NH3 and H2S (biomarkers for kidney
disorders) in a highly humid environment.37 Kahn et al.
designed an array of metal nanoparticle-based flexible sensor to
detect different volatile organic compounds (VOCs) related to
ovarian cancer. Each sensor element of the array was
functionalized with ligands having unique functional groups.38
Ongoing follow up studies focus on strategies to enhance
sensitivity and selectivity and to translate the platform into a
diagnostic tool for clinical use. However, diminishing selectivity
of the sensors because of the complex medium of real breath,
deterioration of signal quality, and the broad variances in
volume/composition of exhaled breath are still significant
challenges to overcome, limiting the potential use of volatilome
analyzers for disease diagnosis.
Herein we report on a hand-held volatilome analyzer for
selective determination of clinically relevant biomarkers acetone
and toluene (metabolic pathways of acetone and toluene given
in SI section in detail). The sensing platform is based on
electrospun polymer nanofiber−multiwalled carbon nanotube
(MWCNT) sensing microchannel. Polymer nanofibers of
poly(vinylidene fluoride) (PVDF), polystyrene (PS), and
poly(methyl methacrylate) (PMMA) incorporated with
MWCNT exhibit high tolerance to interfering humidity and
CO2. The three polymer nanofibers were chosen because of
their varying solubility properties (see Tables S1 and S2) in
acetone and toluene, which are target volatilomes associated
with diabetes and lung cancer. The major advantage provided
by the PVDF nanofiber is the acetone specific deformation in
the presence of interfering species that may exist in the exhaled
breath. Similarly, PS nanofibers exhibit deformations upon
exposure of toluene due to the matching of PS solubility
parameter with toluene. The PMMA nanofibers utilized as
control shows no specific deformations upon exposure of
acetone and toluene. The proposed sensor configuration does
not require sophisticated surface functionalization protocols
exhibit negligible interferences, as long as the target’s and
Scheme 1. Operation and Components of Handheld Analyzer Consisting of an Integrated μ-Card with Electrospun Polymer
MWCNT Microchannels Attached to a Conductivity Monitoring System and a Display Unit (See Figure S2 for Circuit Board
Details)
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nanofiber’s solubility parameter matches. The microchannel
sensing platform consists of a microfluidic cartridge (μ-card)
that facilitates collection and preconcentration of exhaled
breath. The μ-card has a simplistic design and is integrated with
an electronic interface that enables detection of minute
resistivity changes over a large dynamic range. The volatilome
analyzer with the μ-card fitting socket holds great promise for
screening of individuals in different risk groups. The detection
methodology is briefly illustrated in Scheme 1. It enables rapid
screening and extended monitoring of acetone in real breath.
The described methodology provides excellent flexibility,
sensitivity and specificity for future healthcare applications.
The proposed methodology possesses a good potential for low-
cost mass production of volatilome analyzers, enabling
semicontinuous monitoring of VOCs in exhaled breath.
Overall, the described noninvasive methodology enables rapid
screening of volatilomes in breath and could be applicable for
diagnosis of VOC related diseases.
■ EXPERIMENTAL SECTION
Materials. Poly(vinylidene fluoride) (PVDF; average
molecular weight of 275.000 g/mol, Sigma-Aldrich), polystyr-
ene (PS; average molecular weight of 280.000 g/mol, Sigma-
Aldrich), and poly(methyl methacrylate) (PMMA; average
molecular weight of 350.000 g/mol, Sigma-Aldrich) were
utilized for fabrication of polymer nanofibers. Dimethylforma-
mide (DMF, ≥99.8%), dichloromethane (DCM, ≥99%, Sigma-
Aldrich), and acetone were used to dissolve polymers. Nitric
acid (HNO3, ≥65%, Sigma-Aldrich), sulfuric acid (H2SO4),
hydrochloric acid (HCl, ≥37, Sigma-Aldrich), and ammonium
hydroxide (NH4OH, 26%, Sigma-Aldrich)) were used for the
functionalization of MWCNTs. Acetone (ACS Rea. Merck)
and toluene (ACS Rea. Merck) were used as volatilome vapors
for 2-probe resistivity measurements.
Polymethyl methacrylate (PMMA) microchannel was
assembled as a multilayer configuration that composed of
four layers: (1) PMMA base, (2) nanofiber-CNT electro-
chemical membrane, (3) conductive metal tape, and (4)
PMMA microfluidic channel. Sensing microchannel was
designed to collect maximum amount of exhaled breath by
means of a large opening in the front face that directs breath in
to the sensing microchannels.
AFM Analysis. PVDF, PS, and PMMA were electrospun
onto the gold surface that has been decontaminated in UV
ozone cleaner for AFM analysis. Morphology analysis of single
fiber was performed using tapping mode configuration with a
scan size of 8.0 μm and a scan rate of 1.0 Hz. The
characteristics of tip are length = 125 μm, width = 35 μm,
frequency = 150 kHz, k = 5 N/m, and r = 8−12 nm. The
morphology of the fibers was systematically investigated prior
and after solvent exposure. The fibers were purged with N2 for
regeneration.
Electronic System. The electronic system consists of four
main components: resistivity detection and signal conditioning
circuit, microcontroller unit, communication unit that com-
promise a USB, and a Bluetooth low energy module and
display.
A highly sensitive Wheatstone bridge readout circuit was
developed to convert the resistivity changes into voltage
variations upon exhaled breath exposure to the sensing
microchannels. The obtained signals were amplified to about
33-fold using an INA122 single supply instrumentation
amplifier. Subsequently, the signal was amplified again using
the AD820 opamp.
The Wheatstone Bridge (see Scheme 1) consists of four
resistors; R1, R2, R3, and the resistance of sensing microchannel
defined as R4 = Rbase + ΔR, where ΔR is the resistivity variation
upon exhaled breath exposure. In case there is no interaction
between polymer nanofibers and volatilome in exhaled breath
then, R4 = Rbase, thereby the bridge will be in balance. However,
upon any interaction between the analytes in exhaled breath
with the polymer nanofibers, the resistance of R4 changes (R4 =
Rbase + ΔR), subsequently unbalancing the resistance bridge
causing a voltage variation Vbridge according to the equation:
=
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where Vcc is the supply voltage set to 5 V. Arduino Mega 2560
was utilized as the microcontroller unit. The analog voltage
variations were processed by this microprocessor and the
signals were transferred to the display for visualization. The
portable device, see Scheme 1, is a hand-held device that is
sensitive to resistivity changes. The hand-held device is
composed of three components: μ-card integrated circuit
board, electronic biointerfacing circuit, and user communica-
tion interface with display and data transfer units. The
validation experiments were performed by exhaled breath
tests via monitoring the change in voltage variations over the
time, evaluated from the resistivity changes of the sensing
microchannels.
Normal Respiratory Flow Test. The volatilome analyzer
was designed as portable hand-held diagnostic tool that has
three functional units: LCD display, cartridge socket, and signal
processing unit. The cartridge shown in Scheme 1 is made of
sensing microchannels P1, P2, and P3 that were sandwiched
between laser engraved top and bottom plastic substrates. Prior
to volatilome detection, analyzer was first used to perform
normal expiratory flow test to determine reference resistivity
change upon breathing. In a typical analysis operation, analyzer
was positioned at 50 mm from the mouth and exhaled breath
was blown over the cartridge unit. For each analysis, breath is
collected in a Tedlarbag from a healthy volunteer (23 years old,
female).
■ RESULTS AND DISCUSSION
Characterization of Electrospun Polymer Fiber-
MWCNT Microchannels. The sensing microchannels P1,
P2, and P3 consist of polymer nanofibers that were fabricated
by electrospinning. Table 1 shows the spinning parameters such
Table 1. Electrospinning parameters of PVDF, PS, and PMMA
solution conditions spinning conditions
polymer concn (wt %) solvent composition by volume spinning distance (mm) voltage (kV) flow rate (mL/h)
PVDF 25 DMF(4)/acetone(1) 145 23 3.0
PS 15 DCM(4)/DMF(1)/acetone(1) 120 25 3.5
PMMA 20 DMF 210 25 3.5
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as polymer concentration, solvent composition, spinning
distance, voltage, and flow rate that have been optimized to
control the morphology and the average diameter of the
polymer nanofibers. The scanning electron micrographs of
polymer nanofibers of PVDF, PS, and PMMA are shown in
Figure 1.
Figure 1a, d, and g show that the average fiber diameter of
the PVDF fibers are substantially smaller (350(±5.25) nm)
than those of PS (1.8(±0.11) μm) and PMMA (3.6(±0.25)
μm), respectively, and the inset graphs illustrate the distribution
of the fiber diameters. The PVDF and PMMA samples display a
homogeneous distribution of fibers, whereas the PS fibers are
less homogeneous, which is attributed to the formation of
beads. The conductive MWCNT layer is generated on the
polymer fiber mats by deposition from a 2 mg/mL stock
solution with a conductivity of 29.4 μS/cm. The conductive
layer thicknesses are measured to be 3.5, 8.4, and 5.6 μm for
PVDF, PS, and PMMA, respectively (side view of sensing
platforms are indicated by white arrows in Figure 1c,f,i). Cracks
of varying sizes in the MWCNT coatings are seen for all PVDF,
PMMA, and PS samples. Image analysis indicates that larger
cracks are formed on PS and PMMA mats due to their higher
average roughness and undulations with respect to those
present on the PVDF mat. The crack sizes of MWCNT on PS
and PMMA are approximately 5× larger than those on PVDF.
Moreover, the average base resistivity of the microchannels P1,
P2, and P3 is ∼5 kΩ/cm.
Figure 2 shows AFM images of PVDF, PS, and PMMA fibers
and the corresponding profile analyses in air and upon exposure
to 1.5 ppm of target volatilomes, acetone and toluene. The fiber
diameters are 700 nm and 1.5 and 2.5 μm for PVDF, PS, and
PMMA, respectively (black curves). Significant deformations
are seen upon acetone exposure. For instance, PVDF fibers
exhibits changes in height and diameter of 14.3 and 9.9%,
respectively (see Figure 2d), whereas toluene introduces
marginal changes in a single PVDF fiber. A substantial change
in height (36.3%) is evident for the PS fiber upon toluene
exposure, contrary to acetone PMMA fibers that display very
small changes in diameter and height upon exposure to acetone
and toluene. The selective deformations of three polymer
nanofibers upon acetone and toluene exposure are attributed to
the relative permeability/solubility of gas molecules in polymer
nanofibers. In order to gain a deeper understanding of the
response of the polymers to the volatilomes, we considered the
established theory relating the polymer solubility to the
cohesive energy between polymer chains through Hildebrand
solubility parameter δ = (−E/V)1/2, where E is the cohesive
energy (energy of vaporization) and V is the molar volume of
the pure solvent.46,47 The total cohesive energy, given by E =
ED + EP + EH, where D, P, and H refer to dispersion, dipole−
Figure 1. SEM images of polymer nanofibers: (a) PVDF nanofiber and PVDF-MWCNT, (b) top view and (c) side view; (d) PS nanofiber and PS-
MWCNT, (e) top view and (f) side view; (g) PMMA nanofiber and PMMA-MWCNT, (h) top view and (i) side view. Insets in a, d, and g show the
distribution of fiber diameter.
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dipole, and hydrogen bonding forces, respectively, is related to
Hansen solubility parameter and the relative energy difference
(RED) for the polymers (Table S3).48 In short, a volatilome
molecule is expected to permeate into the polymer if the RED
value is smaller than “1”, whereas no volatilome permeation
occurs if the RED value is larger than “1”.49 The specific
deformations seen in the PVDF and PS nanofiber networks
upon acetone and toluene exposure correlate well to the RED
values, thereby offering an avenue to differentiate target
volatilomes in exhaled breath. Scheme 2 schematically
illustrates the volatilome-induced nanofiber deformations that
cause displacements and crack formation in the MWCNT
conductive layer and a concomitant change in resistivity.
Sensing Performance and Fabrication of Volatilome
Analyzer. Figure 3a briefly shows the fabrication steps 1−4 of
the sensing microchannel, the integrated μ-card, and the
volatilome analyzer. Figure 3b shows the response to the
collected breath flown over sensing microchannel (P1) at a rate
of 6 L/min, yielding a reproducible relative response ΔR/Rb ∼
1.5% (red trace). The magnified inset graph shows a response
time for adsorption of 7.8 s and desorption of 30 s. An identical
test conducted using the nanofiber-MWCNT layer (black
traces) without microchannel configuration yielded random
and sharp fluctuations with no correlation to exhaled breath
injection. This result indicates that the proposed configuration
of a sensing microchannel with nanofiber-MWCNT coating
yields a reproducible response profile (adsorption/desorption),
facilitating exhaled breath monitoring. Responses to exhaled
breath at varying flow rates categorized as weak (3(±0.15)L/
min), normal (6(±0.3)L/min), and strong (10(±0.5)L/min),
as shown in Figure 3c, yield a maximum voltage deviation of
1.95, 2.15, and 2.25 V, respectively, illustrating a linear relation
between the change in voltage (ΔV) and flow rate.
The volatilome detection capability of the analyzer with the
P1, P2, and P3 sensing microchannels was evaluated by spiking
acetone and toluene into breath samples collected from healthy
donors. Figure 4a shows the acetone response for the three
sensing microchannels for concentrations ranging between 0.3
and 3.2 ppm. The P1 sensing microchannel displays a linear
response for concentrations between 0.3 and 1.7 ppm (at a
sensitivity of 24.4%/ppm). The P2 sensing microchannel
displays a linear dependency throughout the entire concen-
trations regime (0.3−3 ppm), but with a lower sensitivity
5.95%/ppm. The response for the P3 sensing microchannel is
significantly lower with a sensitivity of 1.38%/ppm. Figure 4b
illustrates the responses of the three microchannels with P2
showing the highest sensitivity of 14.3%/ppm between 0.3−1.5
ppm. P1 significantly deviates from linearity in the same
concentration regime. As observed for acetone, P3 also displays
Figure 2. AFM images of polymer nanofibers: PVDF in (a) air, (b)
acetone atmosphere, and (c) toluene atmosphere; PS in (f) air, (g)
acetone atmosphere, and (h) toluene atmosphere; PMMA in (k) air,
(l) acetone atmosphere, and (m) toluene atmosphere. Prnalysis of
PVDF in (d) air (black curve) and acetone atmosphere (red curve);
(e) PVDF in air (black curve) and toluene atmosphere (blue curve);
(i) PS in air (black curve) and acetone atmosphere (red curve); (j) PS
in air (black curve) and toluene atmosphere (blue curve); (n) PMMA
in air (black curve) and acetone atmosphere (red curve); (o) PMMA
in air (black curve) and toluene atmosphere (blue curve).
Scheme 2. Selective Response of the Sensing Microchannel
Relies on the Extent of Volatilome Permeation into the
Polymer Nanofiber Networka
aRED values <1 induce deformation and crack formation in
conductive layer, whereas RED values >1 do not allow for gas
permeation and subsequent deformation and crack formation.
Figure 3. (a) Representation of volatilome analyzer and fabrication
steps to obtain the integrated μ-card: (1) bottom layer with sensing
microchannel reservoir, (2) top layer, (3) sensing microchannel
deposited on top bottom layer, (4) copper electrode deposition. (b)
Typical resistivity graph of μ-card with top sensing layer (red trace)
and without sensing layer (black trace) for exhaled breath. (c) Typical
potential graph of μ-card for exhaled breath at different flow rates.
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a low sensitivity to toluene. Figure 4a,b suggests that P1 and P2
yield selective responses to acetone and toluene. We also
evaluated the signal reproducibility of the three microchannels
by continuously exposing them to short acetone cycles (35 s)
for 4000 s, Figure 5a. The responses of the P1, P2, and P3
microchannels are 24.02 (±2.2), 6.79 (±1.3), and 11.21
(±2.2), respectively. These responses illustrate that the three
microchannels yield reliable and reproducible signals over an
extended period of repetitive exposure to the volatilomes.
Volatilome Analysis in Exhaled Breath. A simple
computational learning scheme was implemented by defining
training sets based on concentration dependent ΔR/Rb
responses of target volatilomes. Here, the exhaled breath is
considered as an input “I” for sensing microchannels P1, P2,
and P3. Figure 6a shows ΔR/Rb responses for increasing
concentrations of volatilomes for P1, P2, and P3 micro-
channels. The variation in signal intensity is less than 2% for
each sensing microchannel at 98% confidence level. Concen-
tration-dependent responses of P1 for acetone and toluene are
denoted as I1 and I1*, respectively. I1 and I1* are normalized by
factorizing the signals with reciprocal values of I1. I2 and I2* are
the response to acetone and toluene of P2 that were normalized
by I2* as described above. I3 and I3* denotes the response of P3
to acetone and toluene, respectively. Figure 6b shows the
normalized response of sensing microchannels where I1, I2*
yield a response of 1 and I1*, I2 yield a response between 0 and
1 that validates the truth table in Figure 6c. The decision
hardware and algorithm principle in Figure 6c responds to the
inputs relying on the outputs summarized in “Decision Table”,
Figure 6d. Resistivity variations at the output of P1 and P2 are
converted into voltage signals and applied to the OPAMP
comparators (see Figure S2 for circuit boards design).
For P1, the normalized response I1 is connected to
noninverting input of comparator, while I1* is connected to
the inverting input. If the input I is above the threshold value
for acetone, then I1 is greater than I1* and Vout‑1 is logic 1. If it
adopts a value below the threshold Vout‑1 is logic 0. A similar
logic is applied for P2. Accordingly, if input I is above the
threshold value for toluene, then I2* is greater than I2 and Vout‑2
is logic 1. The microchannel P3 is used for negative control of
acetone and toluene. Thus, the presence of any components of
these volatilomes in the breath will result in “LOW” level (logic
0) output for Vout‑3. Depending on the logic levels of Vout,
volatilome analyzer responds selectively for acetone or toluene
in breath, for instance, if Vout‑1 = 1, Vout‑2 = 0, and Vout‑3 = 0 the
analyzer utilizes the calibration curve in Figure 4a for detection
of acetone concentration. If the output is Vout‑1 = 0, Vout‑2 = 1,
and Vout‑3 = 0, the analyzer deduces toluene concentration
based on calibration curve in Figure 4b. If the output of control
sensing microchannel Vout‑3 = 1, analyzer deduces that neither
acetone nor toluene exist in exhaled breath (Vout‑3 = 1 was set
to eliminate nonspecific response of interfering volatile
organics). Upon validation of the proposed algorithm for
recognition of target volatilomes using the functional training
set, real breath sample from high-risk group individuals were
used for proof of concept demonstration.
The exhaled breath screening of 20 individuals: healthy (10
volunteers) and risk group (10 volunteers, fasting blood sugar
levels are between 100 and 125 mg/dL, considered as
prediabetic) were tested. In a typical operation, the volatilome
analyzer was first set to autozero (P3 response) and then the
test was initialized upon exhaling. As described previously, the
presence of acetone will result in “HIGH” level (logic 1,
yielding outputs, Vout‑1 = 1, Vout‑2 = 0, Vout‑3 = 0); subsequently,
the concentration will be deduced based on calibration curve
(Figure 4a). Figure 7 illustrates that the acetone response of
healthy group is around 1.8 ΔR/Rb (%), whereas the risk
group’s responses scatters between 2.9 and 5.3 ΔR/Rb (%).
The dotted line indicates the threshold acetone level in breath
that corresponds to 10 ppm. All of the risk group individuals
exhibit high levels of acetone with respect to threshold level,
whereas the responses of healthy volunteers was observed to be
either around or below the threshold level. The responses
indicate that acetone concentration in exhaled breath of risk
groups exhibit positive correlation and t test was performed
with unequal variances for the differentiation of acetone in
exhaled breath of risk group individuals from the healthy group.
The t test yield a t value of 5.36 (tstat > tcritical = 2.16)
corresponding to a statistically significant deviation as
compared to the response of healthy group.
■ CONCLUSIONS
We have described a volatilome analyzer consisting of polymer
nanofiber-multiwalled carbon nanotube composite sensing
Figure 4. (a) Concentration-dependent acetone responses of PVDF (P1), PS (P2), and PMMA (P3). (b) Concentration dependent toluene
responses of PVDF (P1), PS (P2), and PMMA (P3). The inset graphs in a and b show the concentration-dependent real-time responses of P1, P2,
and P3 for acetone and toluene.
Figure 5. Signal reproducibility of (a) P1, (b) P2, and (c) P3
microchannels under sequential exposure to 0.9 ppm acetone pulses (2
min) during 4000 s.
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microchannel that respond selectively to acetone between the
concentration range of 35 ppb and 3.0 ppm and toluene
between 1 ppb and 10 ppm in exhaled breath. The suggested
nanofiber based sensing platform enhances volatilome capture,
thereby offering sensitive detection owing to the higher surface-
to-volume ratio of nanofibers. Moreover, these homogeneous
nanofibers induce uniform CNT deposition across the sensing
interface, which is critical for sensor performance as well as
repeatability. The selective deformation of polymer nanofibers
upon volatilome exposure is attributed to the relative
permeability of gas molecules in polymer nanofiber. With a
sensitivity of 24.4%/ppm and a low deviation in %ΔR/Rb,
PVDF-MWCNT (P1) sensing microchannel enabled acetone
detection from exhaled breath at clinically relevant concen-
tration levels.
The volatilome analyzer and the proposed protocol for
acetone screening possess the potential to facilitate prediabetic
diagnosis of large group of individuals in a short time scale
without blood sample collection. The correlation of proposed
methodology with GC/Q-TOF-MS was found to be 98% in
acetone detection (see Figure S4). Overall, the described
methodology enables facile screening of acetone in exhaled
breath by a-minute-long noninvasive test and could also be
useful for diagnosis of VOC diseases.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.anal-
chem.7b05187.
Experimental details, simulation results, and Hansen and
Hildebrand and solubility parameter tables (PDF).
Figure 6. (a) Volatilome responses of the sensing microchannels with increasing acetone concentrations (left) and toluene concentrations (right).
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Actuators, B 2015, 213, 20−26.
(42) Wang, X.; Ugur, A.; Goktas, H.; Chen, N.; Wang, M.; Lachman,
N.; Kalfon-Cohen, E.; Fang, W.; Wardle, B. L.; Gleason, K. K. ACS
Sensors 2016, 1, 374−383.
(43) Yoo, K.-P.; Lim, L.-T.; Min, N.-K.; Lee, M. J.; Lee, C. J.; Park,
C.-W. Sens. Actuators, B 2010, 145, 120−125.
(44) Kybert, N. J.; Lerner, M. B.; Yodh, J. S.; Preti, G.; Johnson, A. T.
C. ACS Nano 2013, 7, 2800−2807.
(45) Moon, H. G.; Choi, Y. R.; Shim, Y. S.; Choi, K. I.; Lee, J. H.;
Kim, J. S.; Yoon, S. J.; Park, H. H.; Kang, C. Y.; Jang, H. W. ACS Appl.
Mater. Interfaces 2013, 5, 10591−10596.
(46) Rumens, C. V.; Ziai, M. A.; Belsey, K. E.; Batchelor, J. C.;
Holder, S. J. J. Mater. Chem. C 2015, 3, 10091−10098.
(47) Lee, J. N.; Park, C.; Whitesides, G. M. Anal. Chem. 2003, 75,
6544−6554.
(48) Charles, M. H. Hansen Solubility Parameters: A User’s Handbook,
2nd ed.; CRC Press, 2007.
(49) Salman, R. K.; Salih, J. M. IJMSA 2016, 5, 4858−4863.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.7b05187
Anal. Chem. 2018, 90, 5122−5129
5129
